no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Analysis of mortality in a cohort of 650 cases of bacteremic osteoarticular infections
|
Gomez-Junyent, Joan |
|
2018 |
48 |
2 |
p. 327-333 |
article |
2 |
Cardiovascular disease in ANCA-associated vasculitis: The danger lurking beneath the surface!
|
Misra, Durga Prasanna |
|
2018 |
48 |
2 |
p. e21-e22 |
article |
3 |
Clinical value of autoantibodies for lupus myelitis and its subtypes: A systematic review
|
Oiwa, Hiroshi |
|
2018 |
48 |
2 |
p. 214-220 |
article |
4 |
Dactylitis: A hallmark of psoriatic arthritis
|
Kaeley, Gurjit S. |
|
2018 |
48 |
2 |
p. 263-273 |
article |
5 |
Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis
|
Jeong, Seri |
|
2018 |
48 |
2 |
p. 334-342 |
article |
6 |
Dynamic patterns and predictors of hydroxychloroquine nonadherence among Medicaid beneficiaries with systemic lupus erythematosus
|
Feldman, Candace H. |
|
2018 |
48 |
2 |
p. 205-213 |
article |
7 |
Editorial Board
|
|
|
2018 |
48 |
2 |
p. ii |
article |
8 |
Efficacy and safety of repeated courses of hyaluronic acid injections for knee osteoarthritis: A systematic review
|
Altman, Roy |
|
2018 |
48 |
2 |
p. 168-175 |
article |
9 |
How is symptom flare defined in musculoskeletal conditions: A systematic review
|
Costa, Nathalia |
|
2018 |
48 |
2 |
p. 302-317 |
article |
10 |
Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitis
|
Kumar, Bharat |
|
2018 |
48 |
2 |
p. 283-287 |
article |
11 |
Is abnormal glucose tolerance or diabetes a risk factor for knee, hip, or hand osteoarthritis? A systematic review
|
Dawson, Luke P. |
|
2018 |
48 |
2 |
p. 176-189 |
article |
12 |
Measurement properties of patient reported outcome measures for spondyloarthritis: A systematic review
|
Png, Kelly |
|
2018 |
48 |
2 |
p. 274-282 |
article |
13 |
Membrane attack complex (mac) deposition in lupus nephritis is associated with hypertension and poor clinical response to treatment
|
Wang, Shudan |
|
2018 |
48 |
2 |
p. 256-262 |
article |
14 |
Paternal exposure to antirheumatic drugs—What physicians should know: Review of the literature
|
Micu, M.C. |
|
2018 |
48 |
2 |
p. 343-355 |
article |
15 |
Periarticular bone predicts knee osteoarthritis progression: Data from the Osteoarthritis Initiative
|
Lo, Grace H. |
|
2018 |
48 |
2 |
p. 155-161 |
article |
16 |
Phenotypic characterization of patients with rheumatologic manifestations of common variable immunodeficiency
|
Gutierrez, Maria J. |
|
2018 |
48 |
2 |
p. 318-326 |
article |
17 |
Predictive value of early structural changes on radiographs and MRI for incident clinical and radiographic knee osteoarthritis in overweight and obese women
|
Bijen, Claudia Bernadette Maria |
|
2018 |
48 |
2 |
p. 190-197 |
article |
18 |
Predictors of hypogammaglobulinemia during rituximab maintenance therapy in rheumatoid arthritis: A 12-year longitudinal multi-center study
|
Boleto, G. |
|
2018 |
48 |
2 |
p. 149-154 |
article |
19 |
Predictors of the effect of bariatric surgery on knee osteoarthritis pain
|
Chen, Shannon X. |
|
2018 |
48 |
2 |
p. 162-167 |
article |
20 |
Pulmonary manifestations in late versus early systemic lupus erythematosus: A systematic review and meta-analysis
|
Medlin, Jennifer L. |
|
2018 |
48 |
2 |
p. 198-204 |
article |
21 |
Reducing glucocorticoid duration in ANCA-associated vasculitis: A pilot trial
|
Miloslavsky, Eli M. |
|
2018 |
48 |
2 |
p. 288-292 |
article |
22 |
Resolution of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) during Nivolumab therapy for non-small cell lung cancer: a case report.
|
Filetti, Marco |
|
2018 |
48 |
2 |
p. e17-e20 |
article |
23 |
Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis
|
Stamp, Lisa |
|
2018 |
48 |
2 |
p. 293-301 |
article |
24 |
Systematic review, and meta-analysis of steroid-sparing effect, of biologic agents in randomized, placebo-controlled phase 3 trials for systemic lupus erythematosus
|
Oon, Shereen |
|
2018 |
48 |
2 |
p. 221-239 |
article |
25 |
What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis
|
Rayes, Hanan Al |
|
2018 |
48 |
2 |
p. 240-255 |
article |